More Company News

HUTCHMED

China Approval of Fruquintinib for mCRC
05 Sep 2018Read More

HUTCHMED

2018 Interim Results and Clinical Update
27 Jul 2018Read More

HUTCHMED

Initiation of US Sulfatinib Phase Ib/II Trial in Pancreatic NET and BTC
23 Jul 2018Read More

HUTCHMED

Further Fruquintinib FRESCO Trial Data at ASCO 2018
04 Jun 2018Read More

HUTCHMED

2017 Final Results and Clinical Update
12 Mar 2018Read More

1 … 9 10 11 12
Return to HUTCHMED
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).